Pamidronate disodium

Suppliers

Names

[ CAS No. ]:
57248-88-1

[ Name ]:
Pamidronate disodium

[Synonym ]:
Disodium (3-amino-1-hydroxypropane-1,1-diyl)bis[hydrogen (phosphonate)]
Pamidronate disodium salt
Pamidronate disodium
Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-, sodium salt (1:2)
Dinatrium-(3-amino-1-hydroxypropan-1,1-diyl)bis[hydrogen-(phosphonat)]
APD
Disodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate
MFCD01938386
EINECS 260-647-1
(3-amino-1-hydroxypropane-1,1-diyl)bis[hydrogène (phosphonate)] de disodium
Pamidronate (Disodium)

Chemical & Physical Properties

[ Melting Point ]:
300 °C

[ Molecular Formula ]:
C3H11NNa2O7P2

[ Molecular Weight ]:
281.05

[ PSA ]:
186.59000

[ Appearance of Characters ]:
solid | white

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
H2O: 28 mg/mL

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SZ6525000
CHEMICAL NAME :
Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-, disodium salt
CAS REGISTRY NUMBER :
57248-88-1
LAST UPDATED :
199709
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C3-H9-N-O7-P2.2Na
MOLECULAR WEIGHT :
279.05

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
750 ug/kg/5D-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - visual field changes Sense Organs and Special Senses (Eye) - diplopia Sense Organs and Special Senses (Eye) - effect, not otherwise specified
REFERENCE :
ANZJB8 Australian and New Zealand Journal of Medicine. (Modern Medicine of Australia Pty., Ltd., 100 Pacific Highway, North Sydney, 2060, Australia) V.1- 1971- Volume(issue)/page/year: 24,320,1994
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
600 ug/kg/6H-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - changes in calcium
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 1,622,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
900 ug/kg
TOXIC EFFECTS :
Musculoskeletal - joints
REFERENCE :
APHRER Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26- 1992- Volume(issue)/page/year: 31,499,1997 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1740 mg/kg
SEX/DURATION :
female 15-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,654,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
60 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,654,1992

Safety Information

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R22:Harmful if swallowed. R48:Danger of serious damage to health by prolonged exposure. R41:Risk of serious damage to eyes. R37/38:Irritating to respiratory system and skin . R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .

[ Safety Phrases ]:
S22:Do not breathe dust . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S45:In case of accident or if you feel unwell, seek m

[ WGK Germany ]:
3

[ RTECS ]:
SZ6525000

[ HS Code ]:
2931900090

Customs

[ HS Code ]: 2931900090

[ Summary ]:
2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%


Related Compounds

  • Pamidronate disodium
  • Clodronate disodium tetrahydrate
  • potassium,disodium,2-(4-chloro-2-methylphenoxy)propanoate,methyl-dioxido-oxo-λ5-arsane
  • dimethylglyoxime disodium salt
  • Olsalazine (Disodium)
  • GMP disodium salt
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • (2S)-2-amino-3-(1H-indol-3-yl)-1-(morpholin-4-yl)propan-1-one hydrochloride
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 1-[2-(1-isocyanatocyclopropyl)ethyl]-1H-pyrazole
  • 2-(Difluoromethyl)-9-ethyl-1-oxa-5-azaspiro[5.5]undecane
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde